Correction: Tracking of serum lipids from prepuberty to young adulthood: results from the KiGGS cohort study

Following publication of the original article [1], the authors identified duplicated text within the Background section. They have also requested updates to Table 3, the Statistical Analysis, Methods, Result and Conclusion sections.

The following duplicated texts has been removed:

which affects about 1 in 250 to 500 children and adolescents may benefit from early detection and lipid lowering drug treatment, in order to prevent premature ACSVD [3, 4]. The benefits, risks and implications of universal cholesterol screening in childhood are nevertheless subject to ongoing debate [4–6]. As a much larger proportion of children with elevated lipid levels detected by screening will have multifactorial dyslipidemia requiring coordinated care and follow-up, public health strategies need to carefully designed [4].

The requested updates to Table 3, Statistical Analysis, Methods, Result and Conclusion sections are shown in the below table.

Incorrect	Correct
In methods section:
Of them, 6465 (37%) took part	Of these, 6465 (37%) took part
In Table 3, page 7, Column “% (95%-CI)”:
47.9 (29.0–67.4)	47.1 (29.0–66.0)
27.6 (15.9–43.5)	29.2 (17.7–44.0)
24.5 (8.9–52.0)	23.7 (10.1–46.2)
27.2 (16.4–41.5)	26.6 (16.4–40.2)
29.4 (17.4–45.2)	29.2 (17.3–45.0)
23.8 (27.1–61.4)	44.1 (28.3–61.3)
54.4 (28.8–77.9)	54.5 (31.0-76.2)
32.4 (12.2–62.4)	27.1 (10.6–53.8)
13.2 (4.5–32.5)	18.4 (5.5–46.9)
Table 3 footnote, page 7:
aCut-points for serum lipids according to Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents [36], see Table 1 bN = 692 persons 6–8 years of age at KiGGS baseline and ≥ 18 + years at KiGGS wave 2	aCut-points for serum lipids according to Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents [36], see Table 1. The percentages shown have been rounded to one decimal place, resulting in a deviation of 0.1% from 100% bN = 692 persons 6–8 years of age at KiGGS baseline and ≥ 18 + years at KiGGS wave 2
In Statistical analysis section, page 4:
“…,food diversity index at baseline and follow-up,…”	“…,food diversity index at baseline and difference from baseline to follow-up,…”
In Results section:
Table 3 presents the change in risk categories for the subgroup of children with elevated Non-HDL-C levels at baseline (N = 53). 25% (9–52%) of children with elevated non-HDL-C levels persisted in this category, 28% (16–44%) had borderline levels and 48% (29–67%) had acceptable levels at follow-up. For TC, persistence in the baseline category was 68% (Fig. 2). 42% (36–49%) of children with borderline/high TC levels at baseline remained at the same level at follow-up. 24% (27–61%) of children with elevated TC at baseline (N = 70) remained in their initial category (see Table 3). Persistence of HDL-C levels in the initial category was 74%. 44% (30–58%) of children with borderline/low HDL-C levels at baseline remained in the borderline/low category at follow-up. 13% with low HDL-C at baseline (N = 29) remained in the initial category (see Table 3).	Table 3 presents the change in risk categories for the subgroup of children with elevated non-HDL-C levels at baseline (N = 53). 24% (CI 10–46%) of children with elevated non-HDL-C levels persisted in this category, 29% (CI 18–44%) had borderline levels and 47% (CI 29–67%) had acceptable levels at follow-up. For TC, persistence in the baseline category was 68% (Fig. 2). 42% (36–49%) of children with borderline/elevated TC levels at baseline remained at the same level at follow-up. 44% (CI 28–61%) of children with elevated TC at baseline (N = 70) remained in their initial category (see Table 3). Persistence of HDL-C levels in the initial category was 74%. 44% (30–58%) of children with borderline/low HDL-C levels at baseline remained in the borderline/low category at follow-up (Fig. 2). 18% (6–47%) with low HDL-C at baseline (N = 29) remained in the initial category (see Table 3).
In Conclusion section, page 11:
A large proportion of the variance of lipid levels in young adulthood among female individuals remained unexplained by modifiable determinants requires further investigation.	A large proportion of the variance of lipid levels in young adulthood among female individuals remained unexplained by modifiable determinants, which requires further investigation.

The original article [1] has been corrected.